Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Patel

Showing results (241-250 of 260) with videos related to

Pageof 26
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2014
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformationAnn-Kathrin Eisfeld, Sebastian Schwind, Kevin W Hoag, et al.
Journal of the National Cancer Institute|May 20, 2004
Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancerMark D Pegram, Tadeusz Pienkowski, Donald W Northfelt, et al.
British Journal of Haematology|September 29, 2011
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patientsJames R Berenson, Ori Yellin, Chien-Shing Chen, et al.
Cancer|June 23, 2017
DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancerCharité N Ricker, Diana L Hanna, Cheng Peng, et al.
Science Signaling|April 17, 2014
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathwayAnn-Kathrin Eisfeld, Sebastian Schwind, Ravi Patel, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 19, 2020
Approach to critical illness myopathy and polyneuropathy in the older SARS-CoV-2 patientsBrendan McClafferty, Ibrahim Umer, Gary Fye, et al.
Nature Biomedical Engineering|May 9, 2022
An integrated wearable microneedle array for the continuous monitoring of multiple biomarkers in interstitial fluidFarshad Tehrani, Hazhir Teymourian, Brian Wuerstle, et al.
Communications Biology|March 2, 2019
<sup>90</sup>Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin's LymphomaReinier Hernandez, Kirsti L Walker, Joseph J Grudzinski, et al.
Radiation Research|April 21, 2022
Lactobacillus reuteri Releasing IL-22 (LR-IL-22) Facilitates Intestinal Radioprotection for Whole-Abdomen Irradiation (WAI) of Ovarian CancerDiala F Hamade, Alexis Espinal, Jian Yu, et al.
British Journal of Haematology|October 3, 2006
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm studyJames R Berenson, Ralph Boccia, David Siegel, et al.
Pageof 26

Showing results (241-250 of 260) with videos related to

Sort By:
Pageof 26
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2014
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformationAnn-Kathrin Eisfeld, Sebastian Schwind, Kevin W Hoag, et al.
Journal of the National Cancer Institute|May 20, 2004
Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancerMark D Pegram, Tadeusz Pienkowski, Donald W Northfelt, et al.
British Journal of Haematology|September 29, 2011
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patientsJames R Berenson, Ori Yellin, Chien-Shing Chen, et al.
Cancer|June 23, 2017
DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancerCharité N Ricker, Diana L Hanna, Cheng Peng, et al.
Science Signaling|April 17, 2014
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathwayAnn-Kathrin Eisfeld, Sebastian Schwind, Ravi Patel, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 19, 2020
Approach to critical illness myopathy and polyneuropathy in the older SARS-CoV-2 patientsBrendan McClafferty, Ibrahim Umer, Gary Fye, et al.
Nature Biomedical Engineering|May 9, 2022
An integrated wearable microneedle array for the continuous monitoring of multiple biomarkers in interstitial fluidFarshad Tehrani, Hazhir Teymourian, Brian Wuerstle, et al.
Communications Biology|March 2, 2019
<sup>90</sup>Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin's LymphomaReinier Hernandez, Kirsti L Walker, Joseph J Grudzinski, et al.
Radiation Research|April 21, 2022
Lactobacillus reuteri Releasing IL-22 (LR-IL-22) Facilitates Intestinal Radioprotection for Whole-Abdomen Irradiation (WAI) of Ovarian CancerDiala F Hamade, Alexis Espinal, Jian Yu, et al.
British Journal of Haematology|October 3, 2006
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm studyJames R Berenson, Ralph Boccia, David Siegel, et al.
Pageof 26